These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1888 related articles for article (PubMed ID: 33975825)

  • 1. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
    Prats-Uribe A; Sena AG; Lai LYH; Ahmed WU; Alghoul H; Alser O; Alshammari TM; Areia C; Carter W; Casajust P; Dawoud D; Golozar A; Jonnagaddala J; Mehta PP; Gong M; Morales DR; Nyberg F; Posada JD; Recalde M; Roel E; Shah K; Shah NH; Schilling LM; Subbian V; Vizcaya D; Zhang L; Zhang Y; Zhu H; Liu L; Cho J; Lynch KE; Matheny ME; You SC; Rijnbeek PR; Hripcsak G; Lane JC; Burn E; Reich C; Suchard MA; Duarte-Salles T; Kostka K; Ryan PB; Prieto-Alhambra D
    BMJ; 2021 May; 373():n1038. PubMed ID: 33975825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital.
    Gourieux B; Reisz F; Belmas AS; Danion F; Fourtage M; Nai T; Reiter-Schatz A; Ruch Y; Walther J; Nivoix Y; Michel B
    Eur J Hosp Pharm; 2021 Sep; 28(5):242-247. PubMed ID: 33239282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs.
    Vernaz N; Agoritsas T; Calmy A; Gayet-Ageron A; Gold G; Perrier A; Picard F; Prendki V; Reny JL; Samer C; Stirnemann J; Vetter P; Zanella MC; Zekry D; Baggio S
    Swiss Med Wkly; 2020 Dec; 150():w20446. PubMed ID: 33382449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation study.
    Smith MK; Bikmetov R; Al Rihani SB; Deodhar M; Hafermann M; Dow P; Turgeon J; Michaud V
    Clin Transl Sci; 2021 Sep; 14(5):1799-1809. PubMed ID: 33786990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.
    Kim JW; Kim EJ; Kwon HH; Jung CY; Kim KC; Choe JY; Hong HL
    Korean J Intern Med; 2021 Mar; 36(Suppl 1):S253-S263. PubMed ID: 32536150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortality.
    Rivera-Izquierdo M; Valero-Ubierna MDC; R-delAmo JL; Fernández-García MÁ; Martínez-Diz S; Tahery-Mahmoud A; Rodríguez-Camacho M; Gámiz-Molina AB; Barba-Gyengo N; Gámez-Baeza P; Cabrero-Rodríguez C; Guirado-Ruiz PA; Martín-Romero DT; Láinez-Ramos-Bossini AJ; Sánchez-Pérez MR; Mancera-Romero J; García-Martín M; Martín-delosReyes LM; Martínez-Ruiz V; Jiménez-Mejías E
    Med Clin (Barc); 2020 Nov; 155(9):375-381. PubMed ID: 32773165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective comparison of drugs against COVID-19.
    Tan J; Yuan Y; Xu C; Song C; Liu D; Ma D; Gao Q
    Virus Res; 2021 Mar; 294():198262. PubMed ID: 33333102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biggest COVID-19 trial tests repurposed drugs first.
    Nat Biotechnol; 2020 May; 38(5):510. PubMed ID: 32393915
    [No Abstract]   [Full Text] [Related]  

  • 9. Guillain-Barré syndrome as the first manifestation of SARS-CoV-2 infection.
    Barrachina-Esteve O; Palau Domínguez A; Hidalgo-Torrico I; Viguera Martínez ML
    Neurologia (Engl Ed); 2020; 35(9):710-712. PubMed ID: 32891435
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study.
    Hong W; Park YK; Kim BO; Park SK; Shin J; Jang SP; Park HW; Yang W; Jang J; Jang SW; Hwang TH
    PLoS One; 2022; 17(5):e0267645. PubMed ID: 35507600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience.
    Duarte-Salles T; Vizcaya D; Pistillo A; Casajust P; Sena AG; Lai LYH; Prats-Uribe A; Ahmed WU; Alshammari TM; Alghoul H; Alser O; Burn E; You SC; Areia C; Blacketer C; DuVall S; Falconer T; Fernandez-Bertolin S; Fortin S; Golozar A; Gong M; Tan EH; Huser V; Iveli P; Morales DR; Nyberg F; Posada JD; Recalde M; Roel E; Schilling LM; Shah NH; Shah K; Suchard MA; Zhang L; Zhang Y; Williams AE; Reich CG; Hripcsak G; Rijnbeek P; Ryan P; Kostka K; Prieto-Alhambra D
    Pediatrics; 2021 Sep; 148(3):. PubMed ID: 34049958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we use hydroxychloroquine to treat COVID-19 now?
    Chen J; Liu D; Yin L; Zhang L; Lu H
    Int J Antimicrob Agents; 2021 Jan; 57(1):106173. PubMed ID: 33408016
    [No Abstract]   [Full Text] [Related]  

  • 13. Some drugs for COVID-19.
    Med Lett Drugs Ther; 2020 Apr; 62(1595):49-50. PubMed ID: 32324177
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug treatments for covid-19: living systematic review and network meta-analysis.
    Siemieniuk RA; Bartoszko JJ; Zeraatkar D; Kum E; Qasim A; Martinez JPD; Izcovich A; Lamontagne F; Han MA; Agarwal A; Agoritsas T; Azab M; Bravo G; Chu DK; Couban R; Devji T; Escamilla Z; Foroutan F; Gao Y; Ge L; Ghadimi M; Heels-Ansdell D; Honarmand K; Hou L; Ibrahim Q; Khamis A; Lam B; Mansilla C; Loeb M; Miroshnychenko A; Marcucci M; McLeod SL; Motaghi S; Murthy S; Mustafa RA; Pardo-Hernandez H; Rada G; Rizwan Y; Saadat P; Switzer C; Thabane L; Tomlinson G; Vandvik PO; Vernooij RW; Viteri-García A; Wang Y; Yao L; Zhao Y; Guyatt GH; Brignardello-Petersen R
    BMJ; 2020 Jul; 370():m2980. PubMed ID: 32732190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin, a questionable treatment for COVID-19.
    Belfaqeeh O; Janapala RN; Patel J; Alhashmi A; Pourmand A
    Int J Antimicrob Agents; 2021 Mar; 57(3):106280. PubMed ID: 33476733
    [No Abstract]   [Full Text] [Related]  

  • 16. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
    Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
    Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.
    Echarte-Morales J; Minguito-Carazo C; Del Castillo-García S; Borrego-Rodríguez J; Rodríguez-Santamarta M; Sánchez-Muñoz E; Bergel-García R; González-Maniega C; Prieto-González S; Menéndez-Suarez P; Tundidor-Sanz E; Benito-González T; Fernández-Vázquez F
    J Electrocardiol; 2021; 64():30-35. PubMed ID: 33307378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and management of asymptomatic COVID-19 infection: A systematic review.
    Barboza JJ; Chambergo-Michilot D; Velasquez-Sotomayor M; Silva-Rengifo C; Diaz-Arocutipa C; Caballero-Alvarado J; Garcia-Solorzano FO; Alarcon-Ruiz CA; Albitres-Flores L; Malaga G; Schlagenhauf P; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2021; 41():102058. PubMed ID: 33838319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
    More SA; Patil AS; Sakle NS; Mokale SN
    Virology; 2021 Mar; 555():10-18. PubMed ID: 33421743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 95.